94 results
8-K
EX-99.1
XFOR
X4 Pharmaceuticals Inc
22 May 24
Regulation FD Disclosure
8:09am
associated with burdensome administration Long-term use of antibiotics associated with risk of developing antimicrobial resistance (AMR) and cumulative … , fewer and/or less frequent short-term side effects from medication, fewer and/or less frequent gastrointestinal symptoms, fewer and/or less frequent long
8-K
EX-99.1
XFOR
X4 Pharmaceuticals Inc
7 May 24
X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
6:28am
Long-term debt, including accretion, net of discount
Lease liabilities
Warrant liability
Other liabilities
Total liabilities
Total stockholders
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
at least 4.5-fold versus the TAT-ANC at lower doses. These long-term hematological improvements correlated with fewer infections and reduced numbers … that long-term treatment with mavorixafor was well tolerated and continued to demonstrate beneficial treatment effects, including decreased frequency
8-K
EX-99.1
61emo
29 Apr 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
h5skx6ugb4t8
21 Mar 24
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial
7:43am
8-K
EX-99.1
1jkw 9k51u
9 Nov 23
X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates
8:07am
8-K
EX-99.1
boyt7 qfybf
10 Aug 23
Provides Corporate Updates, and Reports Emerging Data from
6:41am
8-K
EX-99.1
tux 5nxwyu1
4 May 23
X4 Pharmaceuticals Reports First-Quarter 2023 Financial
9:05am
8-K
EX-99.1
idztq24t7 noi1
4 May 23
X4 Pharmaceuticals Reports First-Quarter 2023 Financial
6:42am
8-K
EX-1.1
m0p6fqv
9 Dec 22
X4 Pharmaceuticals Announces Proposed Public Offering
8:46am
424B5
1ytnv
8 Dec 22
Prospectus supplement for primary offering
5:47pm
424B5
lzpiu
6 Dec 22
Prospectus supplement for primary offering
9:52pm
8-K
EX-99.2
r5ah un30
29 Nov 22
X4 Pharmaceuticals Announces Positive Top-Line Results from 4WHIM Global, Pivotal Phase 3 Trial of Once-Daily, Oral Mavorixafor in WHIM Syndrome
4:05pm